Helena Earl
University of Cambridge
Addenbrooke's Hospital
Cambridge Health Authority
Hills Road
Cambridge
CB2 2QQ
United Kingdom
Recent publications
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Lancet.2010;376 :235-244
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study
Breast Cancer Res Treat.2010;122 :787-794
Increase text
Decrease text
Print this page